Mitem Pharma announced on September 25, 2024, that it will acquire DESFERAL® (deferoxamine) globally from Novartis Pharma AG, which Novartis India currently imports and sells in India.
AI Assistant
Novartis India Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.